ABBY HOVATER: Open Payments
NPI 1518588037 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 53 payments from 19 companies in 2025. Trend: 2023 $1,278 · 2024 $1,015 · 2025 $1,029
Food & beverage: $1,029
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 8 | $224 |
| AstraZeneca Pharmaceuticals LP | 8 | $215 |
| Novo Nordisk Inc | 13 | $188 |
| Ardelyx, Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $46 |
| PFIZER INC. | 3 | $45 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $20 |
Products named: VOQUEZNA, Ozempic, AIRSUPRA, IBSRELA, BREZTRI, NURTEC ODT, Symbravo, Wegovy.
Industry payments across AL — which companies pay providers there.
